Login / Signup

The use of composite endpoints in cardiovascular outcome trials for diabetes: A review of 22 randomized clinical trials published since 2008.

Sam Kafai YahyaviPeter Lommer KristensenCarsten HjorthøjKatrine Bagge HansenJesper Krogh
Published in: Diabetes, obesity & metabolism (2024)
To avoid misinterpretation, clinicians and regulatory authorities should be careful when interpreting the results of trials, of which the main outcomes are CEs.
Keyphrases
  • type diabetes
  • glycemic control
  • cardiovascular disease
  • palliative care
  • transcription factor
  • clinical trial
  • metabolic syndrome
  • insulin resistance